You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰林生物(300813.SZ)2020年淨利預增30%-60%
格隆匯 01-26 15:50

格隆匯1月26日丨泰林生物(300813.SZ)披露2020年度業績預吿,公司預計2020年度實現歸屬於上市公司股東的淨利潤4472.84萬元-5505.02萬元,同比增長30%-60%。

報吿期內,公司歸屬於上市公司股東的淨利潤較上年同向上升的主要原因是公司銷售收入保持增長,具體如下:

1、2020年受新冠疫情的影響,公司的滅菌系列產品的銷售快速增長。同時隨着市場的進一步拓展,公司的微生物檢測系列和TOC系列的產品的銷售都有所增長,導致相關產品的收入和毛利增長;

2、公司研發的持續投入、銷售業的拓展、管理的優化和提升,導致相關費用有所增加;

3、報吿期內,預計非經常性損益的金額為670萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account